Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 04/11/17 → 02/4/20 |
Funding
- InVentiv Health Clinical LLC: $9,437.50
Pfizer: A Randomized Double-Blind Phase 3 Study Of Avelumab In Combination With Standard Of Care Chemoradiotherapy (Cisplatin Plus Definitive Radiation Therapy) Versus Standard Of Care Chemoradiotherapy in the Front-Line Treatment of...
- Keresztes, Roger (PI)
- Grossman, Craig (CoPI)
- Kudelka, Andrzej (CoPI)
- Valentine, Edward (CoPI)
Project: Research